LightPath Technologies Secures Exclusive License for U.S. Naval Research Labs Infrared Patent Portfolio
LightPath Technologies (NASDAQ:LPTH) announced an exclusive optical usage license from the U.S. Navy's Naval Research Laboratory to manufacture products using its infrared patent portfolio. This agreement enables access to unique chalcogenide glass compositions, positioning LightPath as a leader in Infrared Optical Solutions. The infrared imaging market is projected to grow from $5.8 billion in 2020 to $8.3 billion by 2025, while multispectral imaging is expected to reach $17.6 billion by 2025. This license allows for better optical systems and expands LightPath's market reach.
- Secured an exclusive optical usage license from the U.S. Navy's Naval Research Laboratory.
- Access to unique chalcogenide glass compositions enhances LightPath's product offerings in infrared optics.
- Infrared imaging market anticipated to grow from $5.8 billion in 2020 to $8.3 billion by 2025.
- Multispectral imaging market estimated to grow from $10.9 billion in 2020 to $17.6 billion by 2025.
- Positioned as a leader in Infrared Optical Solutions with improved design capabilities.
- None.
Unlocks Access to Several Multi-billion Dollar Markets, Including Infrared Imaging and Multispectral Imaging
ORLANDO, FL / ACCESSWIRE / December 1, 2021 / LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," or "we"), a vertically integrated provider of engineered solutions for the global photonics industry, today announced that it has secured an exclusive optical usage license to manufacture products using the infrared patent portfolio developed and owned by the United States Navy's U.S. Naval Research Laboratory (NRL). Along with the Company's existing product portfolio, this technology transfer agreement positions LightPath as the leader in Infrared Optical Solutions, using these new materials to provide superior solutions to what is otherwise available.
The agreement with NRL provides LightPath with access to unique chalcogenide glass compositions to develop more comprehensive optical systems targeting some of the fastest growing infrared (IR) markets, including the IR imaging market which is expected to growth from
Commenting on this historical agreement, LightPath's President and Chief Executive Officer, Sam Rubin stated, "We are elated to have been awarded this exclusive license by the U.S. Navy's prestigious NRL after a lengthy application and diligence process. Having this optical use license for chalcogenide glass materials provides us with a very unique, exclusive and cutting-edge advantage which will in turn allow us to design better optical systems than what are currently available. As a result, we will now be able to access several multi-billion dollar markets as an increasingly important partner for commercial development of engineered solutions for Department of Defense agencies, Defense Industrial Base (DIB), prime contractors and other IR optical imaging businesses."
The NRL is the Department of the Navy's corporate laboratory which employs approximately 3,000 civilian scientists, engineers and support personnel as a scientific and engineering command dedicated to research that drives innovative advances for the U.S. Navy and Marine Corps. from the seafloor to space. The agency turns to the private sector for advancing their technologies on a commercial basis. Given LightPath's proprietary high-volume, cost-effective precision molding capabilities and high-quality chalcogenide Black Diamond™ ("BD6™") glass manufacturing facilities, the Company is uniquely positioned to partner with NRL for the commercialization of its IR glass portfolio.
Mr. Rubin continued, "Over the last few years, we have been seeing a trend of moving away from using Germanium crystals as the main material in Infrared systems, into using synthetic Chalcogenide glass, such as our BD6 infrared glass. However, as opposed to visible optics systems that can use dozens of types of glasses in their designs, infrared optical systems are limited only to a small number of materials that are suitable for that wavelength range, severely limiting the potential capabilities of those systems. As a result, infrared optical systems tend to be larger in size and weight then visible systems, leading to higher cost, which limits the number of applications and industries that have been adopting infrared imaging. Bringing to market these nine types of materials provides designers with materials that have a range of different optical properties such as glass density, transition temperature, spectral performance and expansion characteristics that are critical for performance and ideally are made from moldable, lower cost material. With multiple different glass types to use in a system design, infrared optical systems will become more affordable in size, weight and cost, and will be able to tap into new markets and applications. In addition to providing optical system designers more flexibility and choices of materials, this will also allow us to design and deliver superior optical systems, compare to what is currently considered the state of the art in infrared imaging. We intend to substantially manufacture these products in the United States at the Company's recently expanded headquarters in Orlando, Florida. Our current proprietary BD6 material is being made internally at LightPath's Orlando facilities, alongside multiple molding presses, processing equipment for high efficiency anti-reflective coatings and DLC machines for added lens protection. We are making over 200 kilos per week of chalcogenide glass and may increase our volumetric capacity if demand is so high that it is required within 6 months."
LightPath's BD6 glass for IR applications is made from chalcogenide materials which are increasingly replacing germanium and other crystal materials for IR optics due to lower cost. Germanium, in particular, has been subject to rising or volatile pricing due to the material being primarily sourced from China. LightPath began to replace its IR lens raw materials by offering first BD2, and later BD6, a general-purpose chalcogenide glass. Due to BD6 or chalcogenide glass being lighter and more malleable, LightPath is able to mold lenses for higher quantity commercial applications as compared to slower, more labor intensive and more costly diamond turning of lenses made from germanium glass which is a harder substance. The NRL glasses offer a wide range of refractive indices and wavelength dispersion for optimal chromatic correction. In addition, various thermal constants and mechanical properties give optical designers many choices for athermalizing optical designs. NRL glasses are ideally suited for the infrared imaging market which is estimated to grow by over
Optics for multispectral imaging is another fast-growing market where NRL-designed glass would be ideal when mass produced by LightPath. Multispectral imaging involves the process of capturing in one camera images in multiple spectral ranges. This is emerging as a key technology in medical imaging, drone and satellite imaging and mapping, defense applications, and quality control. NRL materials have been specifically designed for use in multispectral imaging systems, having a very wide range of applicable wavelengths. These combined end markets forge an opportunity estimated at nearly twice the size of infrared imaging and growing at more than
About the U.S. Naval Research Laboratory
NRL is a scientific and engineering command dedicated to research that drives innovative advances for the U.S. Navy and Marine Corps from the seafloor to space and in the information domain. NRL is located in Washington, D.C. with major field sites in Stennis Space Center, Mississippi; Key West, Florida; Monterey, California, and employs approximately 3,000 civilian scientists, engineers and support personnel.
About LightPath Technologies
LightPath Technologies, Inc. (NASDAQ:LPTH) is a leading global, vertically integrated provider of optics, photonics and infrared solutions for the industrial, commercial, defense, telecommunications, and medical industries. LightPath designs and manufactures proprietary optical and infrared components including molded glass aspheric lenses and assemblies, custom molded glass freeform lenses, infrared lenses and thermal imaging assemblies, fused fiber collimators, and proprietary Black Diamond™ ("BD6") chalcogenide-based glass lenses. LightPath also offers custom optical assemblies, including full engineering design support. The Company is headquartered in Orlando, Florida, with manufacturing and sales offices in Latvia and China.
LightPath's wholly-owned subsidiary, ISP Optics Corporation, manufactures a full range of infrared products from high performance MWIR and LWIR lenses and lens assemblies. ISP's infrared lens assembly product line includes athermal lens systems used in cooled and un-cooled thermal imaging cameras. Manufacturing is performed in-house to provide precision optical components including spherical, aspherical and diffractive coated infrared lenses. ISP's optics processes allow it to manufacture its products from all important types of infrared materials and crystals. Manufacturing processes include CNC grinding and CNC polishing, diamond turning, continuous and conventional polishing, optical contacting and advanced coating technologies.
For more information on LightPath and its businesses, please visit www.lightpath.com.
Forward-Looking Statements
This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, and include, for example, statements related to the expected effects on the Company's business from the COVID-19 pandemic. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the duration and scope of the COVID-19 pandemic and impact on the demand for the Company products; the ability of the Company to obtain needed raw materials and components from its suppliers; actions governments, businesses, and individuals take in response to the pandemic, including restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps that the Company could take to reduce operating costs; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; and those factors detailed by LightPath Technologies, Inc. in its public filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on 10-Q. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Jordan Darrow
Darrow Associates, Inc.
Tel: 512-551-9296
jdarrow@darrowir.com
1 https://www.marketsandmarkets.com/Market-Reports/infrared-IR-sensing-imaging-market-593.html
2 https://www.grandviewresearch.com/industry-analysis/hyperspectral-imaging-systems-market
SOURCE: LightPath Technologies, Inc.
View source version on accesswire.com:
https://www.accesswire.com/675387/LightPath-Technologies-Secures-Exclusive-License-for-US-Naval-Research-Labs-Infrared-Patent-Portfolio
FAQ
What is the significance of LightPath Technologies' optical usage license from the U.S. Navy?
How will the agreement with the U.S. Navy affect LightPath Technologies' market position?
What growth is expected in the infrared imaging market?
What is the projected growth for the multispectral imaging market?
How does LightPath Technologies plan to manufacture its infrared optics?
